Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection
- 31 March 1997
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 36 (3) , 495-496
- https://doi.org/10.1016/s0190-9622(97)80242-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Rapid Development of Resistance to Clarithromycin Following Monotherapy for Disseminated Mycobacterium chelonae Infection in a Heart Transplant PatientClinical Infectious Diseases, 1995
- Clinical Trial of Clarithromycin for Cutaneous (Disseminated) Infection due to Mycobacterium chelonaeAnnals of Internal Medicine, 1993
- Treatment of Mycobacterium chelonae-induced skin infection with clarithromycinJournal of the American Academy of Dermatology, 1993
- Skin, Soft Tissue, and Bone Infections Due to Mycobacterium chelonae chelonae: Importance of Prior Corticosteroid Therapy, Frequency of Disseminated Infections, and Resistance to Oral Antimicrobials Other than ClarithromycinThe Journal of Infectious Diseases, 1992
- Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial Agents and Chemotherapy, 1992
- Mycobacterium chelonae: A cause of nodular skin lesions with a proclivity for renal transplant recipientsThe American Journal of Medicine, 1989
- Mycobacterium chelonaeWound Infections after Plastic Surgery Employing Contaminated Gentian Violet Skin-Marking SolutionNew England Journal of Medicine, 1987
- Mycobacteria Other than Mycobacterium tuberculosis: Review of Microbiologic and Clinical AspectsClinical Infectious Diseases, 1987
- Injection Site Abscesses Caused by Mycobacterium CheloneiInfection Control, 1983